Stephen J. Gwyther

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

Medicine, Oncology, Treatment Planning +14

RECIST 1.1—Update and clarification: From the RECIST committee

Lawrence H. Schwartz, Saskia Litière, Elisabeth G.E. de Vries et al. · European Journal of Cancer · 2016 · 1.9K citations

Agriculture, Public Policy, Separation Of Powers +3

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial

Tim Maughan, Jonathan A. Ledermann, C. Topham et al. · The Lancet · 2007 · 568 citations

Medicine, Oncology, Chemotherapy +10

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial

Sarah Brown, Gary Middleton, Tim Maughan et al. · The Lancet Oncology · 2013 · 392 citations · Full text

Medicine, Oncology, Pharmacology +12

Evaluation of lymph nodes with RECIST 1.1

Lawrence H. Schwartz, Jan Bogaerts, Robert Ford et al. · European Journal of Cancer · 2008 · 297 citations

Medicine, Oncology, Cervical Lymph Node Surgery +10